Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

SB-1518 dose selected for phase II evaluation in myelofibrosis

June 29, 2010

Phase III data released on tanezumab in knee osteoarthritis pain

June 29, 2010

Pardoprunox is effective in PD but dose adjustment is needed

June 28, 2010

Phase III data detailed for add-on safinamide in PD

June 28, 2010

First-in-human data presented on MLN-9708 in nonhematologic cancer

June 28, 2010

RAD-1901 is efficacious in phase IIa trial in postmenopausal women

June 28, 2010

GDNF gene therapy shows promise in Parkinson's disease model

June 28, 2010

TRC-093 shows promise in phase I trial in patients with solid tumors

June 25, 2010

Genentech suspends development of MTRX-1011A in rheumatoid arthritis

June 25, 2010

CYP3A4 inducers and presence of food affect lurasidone exposure

June 25, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...